bile duct disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Part I: Burden of ERCP a) Patient is undergoing an ERCP at the Erasmus MC-University Medical Center Rotterdam or University Medical Center Utrecht b) Informed consent Part II: Patient preference for common bile duct stone (CBDS) treatment a) Patient is undergoing an ERCP for CBDS b) Patient is referred from the Erasmus MC-University Medical Center Rotterdam or University Medical Center Utrecht c) Patient participates in Part I d) Informed consent
Exclusion criteria
Exclusion criteria: Part I: Burden of ERCP a) Patient is referred from another hospital b) Not being able to fill out the questionnaire Part II: Patient preference for CBDS treatment a) Patient is referred from another hospital b) Not able to fill in the questionnaire c) Comorbid disease (e.g. malignancy, terminal illness, WHO performance score of 4)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Part I: Burden of ERCP Part II: Patient preferences for CBDS treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Part I: Physical symptoms (throat ache, nausea etc), quality of life and functional results (Bilirubine, ALAT, ASAT etc). Part II: The relevance and importance of determinants of patient preferences for CBDS treatment (characteristics of the treatment options, and respondent characteristics) | — |
Countries
Netherlands